COVID-19 update from the UF Health Proton Therapy Institute – READ MORE
UF Health Proton Therapy Institute takes steps to formalize agreement in China for patient treatment and clinical research
On January 12, 2018, in Beijing, China, leaders with GlobalMD Network Corporation and the UF Health Proton Therapy Institute, Jacksonville, Florida, signed Memorandums of Understanding (MOUs) to establish a Sino-American Pediatric Neuro-Oncology Program.
UF Health Proton Therapy Institute Executive Director Stuart Klein along with Tim Shi, MD, PhD, Chief Officer for GlobalMD, China Office, represented their respective organizations at the signing, held at the Chinese Academy of Sciences Automation Institute in Beijing. Following the signing, key Chinese opinion leaders and oncologists met with the group from Jacksonville to learn more about proton therapy for children who have cancer.
The initiative will formalize relationships between the Proton Therapy Institute and children’s hospitals across China to enhance and develop new treatments for children for life-threatening brain, skull-base and spinal tumors.
The Sino-American Pediatric Neuro-Oncology Program will include collaboration in:
Advanced training of physicians and nurses in pediatric neuro-oncologic and other pediatric health conditions
Teleconsultation for pediatric patients in China referred through GlobalMD and the UF Health Proton Therapy Institute
Provision of gold-standard treatment protocols for referred pediatric patients, including proton therapy, chemotherapy, neurosurgery and other treatments for these complex disorders
Tele-monitoring and evaluation of the outcomes of post-cancer treatment patients once they return home
Neuro-oncology research in China and Jacksonville
This program falls under the joint mission of the Sino-American Collaboration Project on Clinical and Translational Medicine, established in 2010.
UF Health Proton Therapy Institute’s Executive Director Stuart Klein said the program, when fully executed, will build on successful agreements with other countries, including the United Kingdom, Norway and the Canadian Provinces of Quebec and Ontario.
“Since opening in 2006, the Institute has seen patients from more than 30 countries, including China, and is the largest pediatric proton therapy program worldwide,” said Klein. “In the past two years since organizing a symposium on radiotherapy in China, the number of patients from China has grown to the point that we have added a staff person who helps Chinese families with communication, transportation and housing needs.”
Join almost 5,000 who receive FREE content to their inbox every time we publish.
To read more articles,
choose a Precision Newsletter below:
Mark your calendar and join us when we are in a town near you.
Aug 29, 10:00am
Duval Car Club Cancer Awareness Fundraising Event & Car Show
Location To Be Determined
About This Newsletter
The Precision Newsletter is an electronic-only publication that is distributed by email. Each issue is sent monthly to patients, alumni patients and friends of the University of Florida Health Proton Therapy Institute. As the official newsletter of the Institute, the content is compiled and prepared by our communications representative and approved by the editor Stuart Klein, executive director of UF Health Proton Therapy Institute. Special bulletin newsletters may occasionally be prepared when timely topics and new developments in proton therapy occur. If you would like to send a Letter to the Editor, please click here.
Keep In Touch
It is easy to stay in touch with us online at floridaproton.org . Look at the top right corner of the homepage for Facebook , Twitter and YouTube icons, click and join us in the social media conversation. Also on the right side of the homepage there is a button for VTOC Patient Portal . Click here to open your secure account, view your records, complete clinical trial questionnaires and communicate with your nurse case manager.
Knowing how you are feeling during and after treatment is essential to providing you the best care possible and contributes to the care of future patients.